/ /

  • linkedin
  • Increase Font
  • Sharebar

    TFOS DEWS II report introduces new patient classification scheme

    Update provides comprehensive, up-to-date review and consensus-based recommendations



    Staged intervention

    The TFOS DEWS II Management and Therapy Subcommittee report presents a severity-related management algorithm comprised of four steps. The recommendations represent evidence-based consensus opinion—the report notes that there is a relative lack of Level 1 evidence to support therapeutic recommendations.

    “It is also unfortunate that the treatments for DED have not changed drastically since TFOS DEWS,” he said. “There is, however, greater understanding of the pathophysiology of DED and a greater interest, from clinicians, researchers, and patients alike, that has stimulated further research and the development of novel therapies and better ways to diagnose DED.”

    The inclusion of an Iatrogenic Dry Eye Subcommittee report is new in DEWS II. By emphasizing the roles played by patients and clinicians in causing DED, it also has implications for management.

    “Common iatrogenic causes of DED include cosmetics, contact lens wear and use of topical and systemic medications,” Dr. Nelson said.


    J. Daniel Nelson, MD

    e: [email protected]

    Dr. Nelson is a consultant to Santen and TearSolutions and has a personal financial interest in TearSolutions.


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results